Arepanrix
Influenza A H5 Monovalent Vaccine · KIT · GlaxoSmithKline Biologicals SA
Arepanrix is a kit containing influenza a h5 monovalent vaccine. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- Arepanrix
- Generic Name
- Influenza A H5 Monovalent Vaccine
- NDC Code (Product)
58160-742- Manufacturer
- GlaxoSmithKline Biologicals SA
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125419
- Marketing Start
- 05/11/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Arepanrix used for?
Arepanrix contains Influenza A H5 Monovalent Vaccine. It is a kit taken as directed. Consult your doctor for specific uses.
Is Arepanrix a controlled substance?
Arepanrix is not classified as a controlled substance by the DEA.
What is the generic name for Arepanrix?
The generic name for Arepanrix is Influenza A H5 Monovalent Vaccine. There are no other listed brand versions of Influenza A H5 Monovalent Vaccine.
What is the NDC code for Arepanrix ?
The NDC (National Drug Code) for Arepanrix is 58160-742, listed by GlaxoSmithKline Biologicals SA.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)